A randomized, balanced, open label, crossover, two period, two treatment, two sequence,
single dose, oral bioequivalence study under fasting condition. It is a pivotal study.
To demonstrate the bioequivalence of Metformin 500 mg tablets manufactured by Savipharm
J.S.C, Vietnam and Glucophage® 500 mg tablets of MERCK SANTE in healthy adult human male
subjects under fasting condition and to monitor the safety of the study subjects.